Anthropic PBC priced its initial public offering at $83 per share on the Nasdaq Global Select Market under the ticker ANT. Trading signals from grey markets and European retail brokers suggest shares could debut as high as $105 each, representing a 24% pop. The offering included regional tranches that attracted heavy international demand, notably drawing nearly $1 billion in orders for the UK portion alone. The debut serves as a critical test for the broader artificial intelligence sector following Nvidia leadership shifts and recent Nasdaq volatility.
Key points
The public debut serves as a vital indicator of market demand for artificial intelligence…: The public debut serves as a vital indicator of market demand for artificial intelligence companies following a Nasdaq 100 correction.
Anthropic founders and the firm raised hundreds of millions of dollars directly through d…: Anthropic founders and the firm raised hundreds of millions of dollars directly through distinct regional offering tranches.
Shares are scheduled to commence trading on the Nasdaq under the ticker symbol ANT starti…: Shares are scheduled to commence trading on the Nasdaq under the ticker symbol ANT starting at 9:30 AM ET on November 19, 2026.
Sources checked by our analysis pipeline: 1
Anthropic IPO GMP today: The whole equity universe is eagerly awaiting for one of the biggest listings in the world of initial public offerings. Anthropic PBC IPO is all set to list on the Nasdaq Global Select Market under the ticker symbol ANT. Its grey market premium hints at nearly 24% listing gain.
As all eyes are now on the listing of the Claud chatbot maker’s IPO, here are all the details about what to expect from its listing day performance.
Anthropic PBC IPO: What does the grey market premium hint at?
Claude Chatbot maker’s shares may open as much as 24% higher after the company raised $81.3 billion through its IPO and secured another $26 billion through a separate private placement. Germany, retail broker Lang & Schwartz, indicated that Anthropic shares may list as high as $ 105 on Wednesday, according to another Bloomberg report.
Anthropic IPO details
At the IPO price of $ 83 per share, Anthropic and its founders raised nearly $ 300 million and $ 801 million, respectively, through the dedicated offerings in Britain and on…
The research collaboration leverages artificial intelligence to identify small molecule candidates targeting a strategic, undisclosed cancer pathway. While London-based Isomorphic Labs will apply computational drug design technology, Merck retains full responsibility for downstream clinical testing, manufacturing, and global commercialization. This alliance continues a broader pharmaceutical trend of integrating machine learning into early-stage wet lab pipelines to expedite oncological discovery.
Creators can now build augmented reality experiences by connecting third-party developer utilities directly into their existing production workflows. This cross-platform release broadens accessibility for creators across multiple desktop operating systems while modernizing the company's development pipeline. By embracing outside artificial intelligence environments, the software significantly expands technical options for digital lens design.
The initiative links automated software directly to more than 800 billing organisations, spanning public agencies, healthcare institutions, power companies, and telcos. By delegating routine obligations like fines and loan instalments to bots, the companies aim to remove friction while establishing technical guardrails to mitigate emerging financial risks.